Skip to main content
SpringerLink
Log in

Management of Non-melanoma Skin Cancers: Basal Cell Carcinoma, Squamous Cell Carcinoma

  • Chapter
  • First Online:
Melanoma

Abstract

With non-melanoma skin cancer on the rise, representing the most common malignancy, recognition, as well as an appropriate treatment approach is essential for management of these potentially life-threatening lesions. The growing incidence of cutaneous malignancies has heralded the need for multiple treatment options based on the aggressiveness of the lesion, as well as patient-specific factors determining risk. This chapter will start by discussing the incidence and trends of non-melanoma skin cancer. Next, risk factors for the various types of non-melanoma skin cancers, including both genetic and environmental exposures, will be highlighted. Furthermore, education and preventative factors such as sun safety and nonmelanoma skin cancer prophylaxis measures will also be discussed. The main subtypes of cutaneous pre-cancerous and cancerous lesions including actinic keratosis, squamous cell carcinoma in situ, squamous cell carcinoma, and basal cell carcinoma will be presented in detail. Although surgical intervention remains the mainstay treatment for the management of skin cancers, various other treatment modalities and their indications for use will be outlined in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006;184(1):6–10.

    PubMed  Google Scholar 

  2. Leffell DJ. The scientific basis of skin cancer. J Am Acad Dermatol. 2000;42(1 Pt 2):18–22.

    Article  PubMed  CAS  Google Scholar 

  3. Zanetti R, Rosso S, Martinez C, Nieto A, Miranda A, Mercier M, et al. Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case-control study. Br J Cancer. 2006;94(5):743–51.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. Almahroos M, Kurban AK. Ultraviolet carcinogenesis in nonmelanoma skin cancer. Part I: incidence rates in relation to geographic locations and in migrant populations. Skinmed. 2004;3(1):29–35. quiz 35–6

    Article  PubMed  Google Scholar 

  5. Hemminki K, Zhang H, Czene K. Time trends and familial risks in squamous cell carcinoma of the skin. Arch Dermatol. 2003;139(7):885–9.

    Article  PubMed  Google Scholar 

  6. Karagas MR, Stannard VA, Mott LA, Slattery MJ, Spencer SK, Weinstock MA. Use of tanning devices and risk of basal cell and squamous cell skin cancers. J Natl Cancer Inst. 2002;94(3):224–6.

    Article  PubMed  Google Scholar 

  7. Lichter MD, Karagas MR, Mott LA, Spencer SK, Stukel TA, Greenberg ER. Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. The New Hampshire Skin Cancer Study Group. Arch Dermatol. 2000;136(8):1007–11.

    Article  PubMed  CAS  Google Scholar 

  8. Ott C, Huber S. The clinical significance of cosmic radiation in aviation. Praxis. 2006;95(4):99–106.

    Article  PubMed  CAS  Google Scholar 

  9. Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol. 2002;47(1):1–17. quiz 18–20

    Article  PubMed  Google Scholar 

  10. Comeau S, Jensen L, Cockfield SM, Sapijaszko M, Gourishankar S. Non-melanoma skin cancer incidence and risk factors after kidney transplantation: a Canadian experience. Transplantation. 2008;86(4):535–41.

    Article  PubMed  Google Scholar 

  11. Karagas MR, Cushing GL, Greenberg ER, Mott LA, Spencer SK, Nierenberg DW. Non-melanoma skin cancers and glucocorticoid therapy. Br J Cancer. 2001;85(5):683–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97(6):425–32.

    Article  PubMed  Google Scholar 

  13. Kraemer KH, Lee MM, Andrews AD, Lambert WC. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch Dermatol. 1994;130(8):1018–21.

    Article  PubMed  CAS  Google Scholar 

  14. Summers CG. Albinism: classification, clinical characteristics, and recent findings. Optom Vis Sci. 2009;86(6):659–62.

    Article  PubMed  Google Scholar 

  15. Majewski S, Jablonska S. Skin autografts in epidermodysplasia verruciformis: human papillomavirus-associated cutaneous changes need over 20 years for malignant conversion. Cancer Res. 1997;57(19):4214–6.

    PubMed  CAS  Google Scholar 

  16. Fine J-D, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs. J Am Acad Dermatol. 2009;61(3):387–402. quiz 403–4

    Article  PubMed  Google Scholar 

  17. Kimonis VE, Goldstein AM, Pastakia B, Yang ML, Kase R, DiGiovanna JJ, et al. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am J Med Genet. 1997;69(3):299–308.

    Article  PubMed  CAS  Google Scholar 

  18. Bolognia JL, Brewer YP, Cooper DL. Bazex syndrome (acrokeratosis paraneoplastica). An analytic review. Medicine. 1991;70(4):269–80.

    Article  PubMed  CAS  Google Scholar 

  19. Castori M, Morrone A, Kanitakis J, Grammatico P. Genetic skin diseases predisposing to basal cell carcinoma. Eur J Dermatol. 2012;22(3):299–309.

    PubMed  Google Scholar 

  20. Asgari MM, Ray GT, Geier JL, Quesenberry CP. Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population. J Am Acad Dermatol. 2017;76(4):632–8.

    Article  PubMed  Google Scholar 

  21. Bolognia J. Dermatology. 3rd ed. Philadelphia: Elsevier Saunders; 2012.

    Google Scholar 

  22. cancer.net. Skin cancer (Non-Melanoma): risk factors and prevention; 2016.

    Google Scholar 

  23. Yuspa SH. Cutaneous chemical carcinogenesis. J Am Acad Dermatol. 1986;15(5 Pt 1):1031–44.

    Article  PubMed  CAS  Google Scholar 

  24. Simeonova PP, LUSTER MI. Mechanisms of arsenic carcinogenicity: genetic or epigenetic mechanisms? J Environ Pathol Toxicol Oncol. Begell House. 2000;19(3):281–6.

    PubMed  CAS  Google Scholar 

  25. Australian Cancer Network: CCA. Basal cell carcinoma, squamous cell carcinoma (and related lesions) – a guide to clinical management in Australia. Cancer Council Australia/Australian Cancer Network Sydney; 2008.

    Google Scholar 

  26. Freiman A, Bird G, Metelitsa AI, Barankin B, Lauzon GJ. Cutaneous effects of smoking. J Cutan Med Surg. 2004;8(6):415–23.

    Article  PubMed  Google Scholar 

  27. Iannacone MR, Wang W, Stockwell HG, O’Rourke K, Giuliano AR, Sondak VK, et al. Patterns and timing of sunlight exposure and risk of basal cell and squamous cell carcinomas of the skin--a case-control study. BMC Cancer. 2012;12:417.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Ulrich C, Jürgensen JS, Degen A, Hackethal M, Ulrich M, Patel MJ, et al. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study. Br J Dermatol. 2009;161(Suppl 3):78–84.

    Article  PubMed  Google Scholar 

  29. Wright TI, Spencer JM, Flowers FP. Chemoprevention of nonmelanoma skin cancer. J Am Acad Dermatol. 2006;54(6):933–46. quiz 947–50

    Article  PubMed  Google Scholar 

  30. Rudnick EW, Thareja S, Cherpelis B. Oral therapy for nonmelanoma skin cancer in patients with advanced disease and large tumor burden: a review of the literature with focus on a new generation of targeted therapies. Int J Dermatol. 2016;55(3):249–58. quiz 256, 258

    Article  PubMed  CAS  Google Scholar 

  31. Fu T, Aasi SZ, Hollmig ST. Management of high-risk squamous cell carcinoma of the skin. Curr Treat Options in Oncol. 2016;17(7):34.

    Article  Google Scholar 

  32. Chen AC, Martin AJ, Choy B, Fernández-Peñas P, Dalziell RA, McKenzie CA, et al. A phase 3 randomized trial of Nicotinamide for skin-cancer chemoprevention. N Engl J Med. 2015;373(17):1618–26.

    Article  PubMed  CAS  Google Scholar 

  33. Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet. 1988;1(8589):795–7.

    Article  PubMed  CAS  Google Scholar 

  34. Criscione VD, Weinstock MA, Naylor MF, Luque C, Eide MJ, Bingham SF. Actinic keratoses: natural history and risk of malignant transformation in the veterans affairs topical Tretinoin chemoprevention trial. Cancer. 2009;115(11):2523–30.

    Article  PubMed  Google Scholar 

  35. Gupta AK, Cooper EA, Feldman SR Jr, Fleischer AB Jr. A survey of office visits for actinic keratosis as reported by NAMCS, 1990–1999. National Ambulatory Medical Care Survey. Cutis. 2002;70(2 Suppl):8–13.

    PubMed  Google Scholar 

  36. Yu RC, Pryce DW, Macfarlane AW, Stewart TW. A histopathological study of 643 cutaneous horns. Br J Dermatol. 1991;124(5):449–52.

    Article  PubMed  CAS  Google Scholar 

  37. Schwartz RA. Keratoacanthoma. J Am Acad Dermatol. 1994;30(1):1–19. quiz 20–2

    Article  PubMed  CAS  Google Scholar 

  38. Norgauer J, Rohwedder A, Schaller J. Human papillomavirus and Grzybowski’s generalized eruptive keratoacanthoma. J Am Acad Dermatol. 2003;49(4):771–2.

    Article  PubMed  Google Scholar 

  39. NCCN. National Comprehensive Cancer Network Guidelines; 2017.

    Google Scholar 

  40. Network NCC. Basal cell carcinoma (version1.2017).

    Google Scholar 

  41. August PJ. Cryotherapy of nonmelanoma skin cancer. Clin Dermatol. 1995;13(6):589–92.

    Article  PubMed  CAS  Google Scholar 

  42. Bahner JD, Bordeaux JS. Non-melanoma skin cancers: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies. Clin Dermatol. 2013;31(6):792–8.

    Article  PubMed  Google Scholar 

  43. Kuflik EG. Cryosurgery for skin cancer: 30-year experience and cure rates. Dermatol Surg. 2004;30(2 Pt 2):297–300.

    PubMed  Google Scholar 

  44. Graham GF, Clark LC. Statistical analysis in cryosurgery of skin cancer. Clin Dermatol. 1990;8(1):101–7.

    Article  PubMed  CAS  Google Scholar 

  45. Kokoszka A, Scheinfeld N. Evidence-based review of the use of cryosurgery in treatment of basal cell carcinoma. Dermatol Surg. 2003;29(6):566–71.

    PubMed  Google Scholar 

  46. Telfer NR, Colver GB, Morton CA. Guidelines for the management of basal cell carcinoma. Br J Dermatol. 2008;159(1):35–48.

    Article  PubMed  CAS  Google Scholar 

  47. Divine J, Stefaniwksy L, Reddy R, Padilla P, Hagele T, Patel NS, et al. A comprehensive guide to the surgical management of nonmelanoma skin cancer. Curr Probl Cancer. 2015;39(4):216–25.

    Article  PubMed  Google Scholar 

  48. Graham G. Electrodesiccation and curettage. In: Macfarlane D, editor. Skin cancer management. 1st ed. New York: Springer; 1988. p. 79–82.

    Google Scholar 

  49. Jackson R, Laughlin S. Electrodesiccation and curettage. In: Schwartz RA, editor. Skin cancer. 1st ed. New York: Springer. p. 292–5.

    Chapter  Google Scholar 

  50. NCCN. Basal cell carcinoma (version 1.2017); 2017.

    Google Scholar 

  51. Jackson R. The treatment of skin cancer by electrodesiccation and curettage. J Surg Oncol. 1983;22(2):100.

    Article  PubMed  CAS  Google Scholar 

  52. Roenigk RK, Roenigk HH. Current surgical management of skin cancer in dermatology. J Dermatol Surg Oncol. 1990;16(2):136–51.

    Article  PubMed  CAS  Google Scholar 

  53. Honeycutt WM, Jansen GT. Treatment of squamous cell carcinoma of the skin. Arch Dermatol. 1973;108(5):670–2.

    Article  PubMed  CAS  Google Scholar 

  54. Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Plast Surg. 2003;56(2):85–91.

    Article  PubMed  CAS  Google Scholar 

  55. Rowe DE, Carroll RJ, Day CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;26(6):976–90.

    Article  PubMed  CAS  Google Scholar 

  56. Silverman MK, Kopf AW, Grin CM, Bart RS, Levenstein MJ. Recurrence rates of treated basal cell carcinomas. Part 1: overview. J Dermatol Surg Oncol. 1991;17(9):713–8.

    Article  PubMed  CAS  Google Scholar 

  57. Wolf DJ, Zitelli JA. Surgical margins for basal cell carcinoma. Arch Dermatol. 1987;123(3):340–4.

    Article  PubMed  CAS  Google Scholar 

  58. Brodland DG, Zitelli JA. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1992;27(2 Pt 1):241–8.

    Article  PubMed  CAS  Google Scholar 

  59. Kimyai-Asadi A, Alam M, Goldberg LH, Peterson SR, Silapunt S, Jih MH. Efficacy of narrow-margin excision of well-demarcated primary facial basal cell carcinomas. J Am Acad Dermatol. 2005;53(3):464–8.

    Article  PubMed  Google Scholar 

  60. Narayanan K, Hadid OH, Barnes EA. Mohs micrographic surgery versus surgical excision for periocular basal cell carcinoma. Cochrane Database Syst Rev. 2014;12:CD007041.

    Google Scholar 

  61. Bogdanov-Berezovsky A, Cohen AD, Glesinger R, Cagnano E, Rosenberg L. Risk factors for incomplete excision of squamous cell carcinomas. J Dermatolog Treat. 2005;16(5–6):341–4.

    Article  PubMed  Google Scholar 

  62. Neville JA, Welch E, Leffell DJ. Management of nonmelanoma skin cancer in 2007. Nat Clin Pract Oncol. 2007;4(8):462–9.

    Article  PubMed  Google Scholar 

  63. Gupta AK, Paquet M, Villanueva E, Brintnell W. Interventions for actinic keratoses. Cochrane Database Syst Rev. 2012;12:CD004415.

    PubMed  Google Scholar 

  64. Lebwohl M, Dinehart S, Whiting D, Lee PK, Tawfik N, Jorizzo J, et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. J Am Acad Dermatol. 2004;50(5):714–21.

    Article  PubMed  Google Scholar 

  65. Szeimies R-MM, Gerritsen M-JPJ, Gupta G, Ortonne JP, Serresi S, Bichel J, et al. Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. J Am Acad Dermatol. 2004;51(4):547–55.

    Article  PubMed  Google Scholar 

  66. Korman N, Moy R, Ling M, Matheson R, Smith S, McKane S, et al. Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials. Arch Dermatol. 2005;141(4):467–73.

    Article  PubMed  CAS  Google Scholar 

  67. Fecker LF, Stockfleth E, Nindl I, Ulrich C, Forschner T, Eberle J. The role of apoptosis in therapy and prophylaxis of epithelial tumours by nonsteroidal anti-inflammatory drugs (NSAIDs). Br J Dermatol. 2007;156(Suppl 3):25–33.

    Article  PubMed  CAS  Google Scholar 

  68. Metterle L, Russell JS, Patel NS. An overview of the medical management of nonmelanoma skin cancer. Curr Probl Cancer. 2015;39(4):226–36.

    Article  PubMed  Google Scholar 

  69. Wolf JE, Taylor JR, Tschen E, Kang S. Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol. 2001;40(11):709–13.

    Article  PubMed  CAS  Google Scholar 

  70. Gebauer K, Brown P, Varigos G. Topical diclofenac in hyaluronan gel for the treatment of solar keratoses. Australas J Dermatol. 2003;44(1):40–3.

    Article  PubMed  Google Scholar 

  71. Lebwohl M, Shumack S, Stein Gold L, Melgaard A, Larsson T, Tyring SK. Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses. JAMA Dermatol. 2013;149(6):666–70.

    Article  PubMed  CAS  Google Scholar 

  72. Anderson L, Schmieder GJ, Werschler WP, Tschen EH, Ling MR, Stough DB, et al. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis. J Am Acad Dermatol. 2009;60(6):934–43.

    Article  PubMed  Google Scholar 

  73. Lebwohl M, Swanson N, Anderson LL, Melgaard A, Xu Z, Berman B. Ingenol mebutate gel for actinic keratosis. N Engl J Med. 2012;366(11):1010–9.

    Article  PubMed  CAS  Google Scholar 

  74. Arits AHH, Mosterd K, Essers BA, Spoorenberg E, Sommer A, De Rooij MJ, et al. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Lancet Oncol. 2013;14(7):647–54.

    Article  PubMed  CAS  Google Scholar 

  75. Bargman H, Hochman J. Topical treatment of Bowen’s disease with 5-Fluorouracil. J Cutan Med Surg. 2003;7(2):101–5.

    Article  PubMed  Google Scholar 

  76. Shumack S, Robinson J, Kossard S, Golitz L, Greenway H, Schroeter A, et al. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens. Arch Dermatol. 2002;138(9):1165–71.

    Article  PubMed  CAS  Google Scholar 

  77. Schiessl C, Wolber C, Tauber M, Offner F, Strohal R. Treatment of all basal cell carcinoma variants including large and high-risk lesions with 5% imiquimod cream: histological and clinical changes, outcome, and follow-up. J Drugs Dermatol. 2007;6(5):507–13.

    PubMed  Google Scholar 

  78. Williams HC, Bath-Hextall F, Ozolins M, Armstrong SJ, Colver GB, Perkins W, et al. Surgery versus 5% Imiquimod for nodular and superficial basal cell carcinoma: 5-year results of the SINS randomized controlled trial. J Invest Dermatol. 2017;137(3):614–9.

    Article  PubMed  CAS  Google Scholar 

  79. Siller G, Rosen R, Freeman M, Welburn P, Katsamas J, Ogbourne SM. PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomized phase IIa trial. Australas J Dermatol. 2010;51(2):99–105.

    Article  PubMed  Google Scholar 

  80. Chitwood K, Etzkorn J, Cohen G. Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons. Dermatol Surg. 2013;39(9):1306–16.

    Article  PubMed  CAS  Google Scholar 

  81. Kirby JS, Miller CJ. Intralesional chemotherapy for nonmelanoma skin cancer: a practical review. J Am Acad Dermatol. 2010;63(4):689–702.

    Article  PubMed  CAS  Google Scholar 

  82. Kraus S, Miller BH, Swinehart JM, Shavin JS, Georgouras KE, Jenner DA, et al. Intratumoral chemotherapy with fluorouracil/epinephrine injectable gel: a nonsurgical treatment of cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1998;38(3):438–42.

    Article  PubMed  CAS  Google Scholar 

  83. Jarkowski A, Hare R, Loud P, Skitzki JJ, Kane JM, May KS, et al. Systemic therapy in advanced cutaneous squamous cell carcinoma (CSCC): the Roswell Park experience and a review of the literature. Am J Clin Oncol. 2016;39(6):545–8.

    Article  PubMed  CAS  Google Scholar 

  84. Denic S. Preoperative treatment of advanced skin carcinoma with cisplatin and bleomycin. Am J Clin Oncol. 1999;22(1):32–4.

    Article  PubMed  CAS  Google Scholar 

  85. Guthrie TH, Porubsky ES, Luxenberg MN, Shah KJ, Wurtz KL, Watson PR. Cisplatin-based chemotherapy in advanced basal and squamous cell carcinomas of the skin: results in 28 patients including 13 patients receiving multimodality therapy. J Clin Oncol. 1990;8(2):342–6.

    Article  PubMed  Google Scholar 

  86. Sadek H, Azli N, Wendling JL, Cvitkovic E, Rahal M, Mamelle G, et al. Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin. Cancer. 1990;66(8):1692–6.

    Article  PubMed  CAS  Google Scholar 

  87. Santana AL, Felsen D, Carucci JA. Interleukin-22 and cyclosporine in aggressive cutaneous squamous cell carcinoma. Dermatol Clin. 2017;35(1):73–84.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  88. Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD, et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med. 2012;366(23):2171–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  89. Migden MR, Guminski A, Gutzmer R, Dirix L, Lewis KD, Combemale P, et al. Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial. Lancet Oncol. 2015;16(6):716–28.

    Article  PubMed  CAS  Google Scholar 

  90. Honeychurch J, Cheadle EJ, Dovedi SJ, Illidge TM. Immuno-regulatory antibodies for the treatment of cancer. Expert Opin Biol Ther. 2015;15(6):787–801.

    Article  PubMed  CAS  Google Scholar 

  91. Cook J, Zitelli JA. Mohs micrographic surgery: a cost analysis. J Am Acad Dermatol. 1998;39(5 Pt 1):698–703.

    Article  PubMed  CAS  Google Scholar 

  92. Willey A, Mehta S, Lee PK. Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy. Dermatol Surg. 2010;36(5):652–8.

    Article  PubMed  CAS  Google Scholar 

  93. Marmur ES, Schmults CD, Goldberg DJ. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg. 2004;30(2 Pt 2):264–71.

    PubMed  Google Scholar 

  94. Rhodes LE, de Rie M, Enström Y, Groves R, Morken T, Goulden V, et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch Dermatol. 2004;140(1):17–23.

    Article  PubMed  CAS  Google Scholar 

  95. Cherpelis BS, Marcusen C, Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg. 2002;28(3):268–73.

    PubMed  Google Scholar 

  96. Schmults CD, Karia PS, Carter JB, Han J, Qureshi AA. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study. JAMA Dermatol. 2013;149(5):541–7.

    Article  PubMed  Google Scholar 

  97. Jambusaria-Pahlajani A, Hess SD, Katz KA, Berg D, Schmults CD. Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeons. Arch Dermatol. 2010;146(11):1225–31.

    Article  PubMed  Google Scholar 

  98. Weinberg AS, Ogle CA, Shim EK. Metastatic cutaneous squamous cell carcinoma: an update. Dermatol Surg. 2007;33(8):885–99.

    PubMed  CAS  Google Scholar 

  99. Kauvar AN, Arpey CJ, Hruza G, Olbricht SM, Bennett R, Mahmoud BH. Consensus for nonmelanoma skin cancer treatment, part II: squamous cell carcinoma, including a cost analysis of treatment methods. Dermatol Surg. 2015;41(11):1214–40.

    Article  PubMed  CAS  Google Scholar 

  100. Kauvar AN, Cronin T, Roenigk R, Hruza G, Bennett R. Consensus for nonmelanoma skin cancer treatment: basal cell carcinoma, including a cost analysis of treatment methods. Dermatol Surg. 2015;41(5):550–71.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology and Cutaneous Surgery, Morsani College of Medicine, University of South Florida, Tampa, FL, USA

    Sheila Jalalat M.D., Neil Alan Fenske M.D. & Basil Cherpelis M.D.

  2. Morsani College of Medicine, University of South Florida, Tampa, FL, USA

    Corin Agoris B.S., B.A.

Authors
  1. Sheila Jalalat M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Corin Agoris B.S., B.A.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Neil Alan Fenske M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Basil Cherpelis M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Basil Cherpelis M.D. .

Editor information

Editors and Affiliations

  1. Louisiana State University, New Orleans, Louisiana, USA

    Adam I. Riker

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Jalalat, S., Agoris, C., Fenske, N.A., Cherpelis, B. (2018). Management of Non-melanoma Skin Cancers: Basal Cell Carcinoma, Squamous Cell Carcinoma. In: Riker, A. (eds) Melanoma. Springer, Cham. https://doi.org/10.1007/978-3-319-78310-9_37

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-78310-9_37

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-78309-3

  • Online ISBN: 978-3-319-78310-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation